Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahreddin Palaz

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|December 6, 2023
Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular DystrophyFahreddin Palaz
Pediatric Discovery|July 8, 2025
Assessing the potential of <i>DZIP1L</i> gene in autosomal recessive polycystic kidney disease gene therapyFahreddin Palaz
The Lancet. Oncology|July 31, 2025
CRISPR-engineered T-cell therapies: some clarifications neededFahreddin Palaz, Sergio Duarte, Ali Zarrinpar
ACS Synthetic Biology|February 1, 2024
Applications of CRISPR Epigenome Editors in Tumor Immunology and AutoimmunityBerkay Yahsi, Fahreddin Palaz, Pervin Dincer
Journal of Hepatocellular Carcinoma|June 4, 2024
CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular CarcinomaFahreddin Palaz, Mehmet Ozsoz, Ali Zarrinpar, et al.
Clinical Biochemistry|January 11, 2021
CRISPR-based tools: Alternative methods for the diagnosis of COVID-19Fahreddin Palaz, Ali Kerem Kalkan, Abdullah Tozluyurt, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection MethodsKasturi Selvam, Mohamad Ahmad Najib, Muhammad Fazli Khalid, et al.
Biotechnology Advances|February 9, 2023
Improving recombinant protein production in CHO cells using the CRISPR-Cas systemAli Kerem Kalkan, Fahreddin Palaz, Semeniuk Sofija, et al.
ACS Synthetic Biology|May 26, 2021
CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and ResearchFahreddin Palaz, Ali Kerem Kalkan, Özgür Can, et al.
Infectious Diseases & Clinical Microbiology|April 18, 2024
Clinical Validation and Evaluation of a Colorimetric SARS-CoV-2 RT-LAMP Assay Against RT-PCRMurat Erdem, Ayşe Andaç-Özketen, Ahmet Çağlar Özketen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|December 6, 2023
Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne's Muscular DystrophyFahreddin Palaz
Pediatric Discovery|July 8, 2025
Assessing the potential of <i>DZIP1L</i> gene in autosomal recessive polycystic kidney disease gene therapyFahreddin Palaz
The Lancet. Oncology|July 31, 2025
CRISPR-engineered T-cell therapies: some clarifications neededFahreddin Palaz, Sergio Duarte, Ali Zarrinpar
ACS Synthetic Biology|February 1, 2024
Applications of CRISPR Epigenome Editors in Tumor Immunology and AutoimmunityBerkay Yahsi, Fahreddin Palaz, Pervin Dincer
Journal of Hepatocellular Carcinoma|June 4, 2024
CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular CarcinomaFahreddin Palaz, Mehmet Ozsoz, Ali Zarrinpar, et al.
Clinical Biochemistry|January 11, 2021
CRISPR-based tools: Alternative methods for the diagnosis of COVID-19Fahreddin Palaz, Ali Kerem Kalkan, Abdullah Tozluyurt, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
RT-LAMP CRISPR-Cas12/13-Based SARS-CoV-2 Detection MethodsKasturi Selvam, Mohamad Ahmad Najib, Muhammad Fazli Khalid, et al.
Biotechnology Advances|February 9, 2023
Improving recombinant protein production in CHO cells using the CRISPR-Cas systemAli Kerem Kalkan, Fahreddin Palaz, Semeniuk Sofija, et al.
ACS Synthetic Biology|May 26, 2021
CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and ResearchFahreddin Palaz, Ali Kerem Kalkan, Özgür Can, et al.
Infectious Diseases & Clinical Microbiology|April 18, 2024
Clinical Validation and Evaluation of a Colorimetric SARS-CoV-2 RT-LAMP Assay Against RT-PCRMurat Erdem, Ayşe Andaç-Özketen, Ahmet Çağlar Özketen, et al.
Pageof 2